Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by RjM2018


ATBPF

RE:RE:Alzheimer's ...

It's very interesting - likely related to a shift in energy source from...

May 13, 2021

ATBPF

RE:RE:Share price taken down

Has anyone ever looked at price depresseion of stocks upon announcing their...

May 13, 2021

ATBPF

RE:A couple of "stupid" questions

P3 further reduces risk. Although we showed statistically signifcant effiacy...

April 23, 2021

ATBPF

RE:RE:RE:Hoping for a rise

I've been holding since before phase 1 and have added significantly over...

April 4, 2021

ATBPF

RE:RE:RE:Antibe's Stomach-Friendly NSAID Keeps Chugging Along

Inthepez - although Otena isn't a prodrug, your explanation of a prodrug&...

April 4, 2021

ATBPF

RE:RE:Ind ame results AH/ATE

I'm pretty sure we need these final long term animal tox studies to be...

March 26, 2021

ATBPF

RE:RE:RE:RE:RE:RE:RE:OA & Back pain worth

Solid Post Mugsy.  I agree with you. From a strategic perspective it is...

March 19, 2021

ATBPF

RE:RE:RE: Insider Buying

Maybe they know something or maybe they just think the stock is severely...

February 27, 2021

ATBPF

RE:RE:RE:RE:RE:RE:Phase 3

Hey Crow,  I actually think it's strategic to go to OTC first from...

February 19, 2021

ATBPF

RE:RE:RE:RE:RE:Canaccord

I don't know where you are getting your info. 1. Median Phase 3 trial...

February 18, 2021

ATBPF

RE:Possible

Absolutely, this is more to do with the other drugs than otena.  After...

February 18, 2021

ATBPF

RE:RE:RE:RE:RE:Lesson Learned

The thought crossed my mind that this could be a raise to buy IP from Antibe...

February 17, 2021

ATBPF

RE:Nuance question

I've researched a bunch of these types of pharma deals in the rare...

February 10, 2021

ATBPF

RE:Derisking

I'd be curious to see the structure of regulatory/milestone payments. In...

February 9, 2021

ATBPF

RE:RE:RE:RE:RE:Analysts are bullish on ATE

Even if the OA market was staying flat, which it is not - CAGR of ~9% until...

February 4, 2021

ATBPF

RE:Deck updated

do you have a link?

February 2, 2021

ATBPF

RE:RE:RE:Corporate update -

Hi MA,  Re: Publishing of animal studies. Publications take time. Once...

January 11, 2021

ATBPF

RE:RE:Mgm’t shares

You are correct MUGMOD - according to Dan on their Biopub presentation last...

July 14, 2020

T.SVA

RE:Presentation

Thanks for sharing - data is really promising. But, the deck they assembled...

June 18, 2020

T.SVA

Alemtuzumab use

Added this to my portfolio late last week. Exciting results - was hoping for...

June 18, 2020

1 2 Next